Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Neuroradiology
Published in: Clinical Neuroradiology 4/2019

01-12-2019 | Original Article

Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy

Authors: Aron S. Talai, Zahinoor Ismail, Jan Sedlacik, Kai Boelmans, Nils D. Forkert

Published in: Clinical Neuroradiology | Issue 4/2019

Login to get access

Abstract

Objectives

The overlapping symptoms of Parkinson’s disease (PD) and progressive supranuclear palsy—Richardson’s syndrome (PSP-RS) often make a correct clinical diagnosis difficult. The volume of subcortical brain structures derived from high-resolution T1-weighted magnetic resonance imaging (MRI) datasets is frequently used for individual level classification of PD and PSP-RS patients. The aim of this study was to evaluate the benefit of including additional morphological features beyond the simple regional volume, as well as clinical features, and morphological features of cortical structures for an automatic classification of PD and PSP-RS patients.

Material and Methods

A total of 98 high-resolution T1-weighted MRI datasets from 76 PD patients, and 22 PSP-RS patients were available for this study. Using an atlas-based approach, the volume, surface area, and surface-area-to-volume ratio (SA:V) of 21 subcortical and 48 cortical brain regions were calculated and used as features for a support vector machine classification after application of a RELIEF feature selection method.

Results

The comparison of the classification results suggests that including all three morphological parameters (volume, surface area and SA:V) can considerably improve classification accuracy compared to using volume or surface area alone. Likewise, including clinical patient features in addition to morphological parameters also considerably increases the classification accuracy. In contrast to this, integrating morphological features of other cortical structures did not lead to improved classification accuracy. Using this optimal set-up, an accuracy of 98% was achieved with only one falsely classified PD and one falsely classified PSP-RS patient.

Conclusion

The results of this study suggest that clinical features as well as more advanced morphological features should be used for future computer-aided diagnosis systems to differentiate PD and PSP-RS patients based on morphological parameters.
Literature
1.
Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. Lancet Neurol. 2006;5:75–86.PubMed
2.
Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson’s disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008;23:2194–201.PubMed
3.
Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G. Neuropsychiatric and cognitive profile of early Richardson’s syndrome, progressive supranuclear Palsy-parkinsonism and Parkinson’s disease. Parkinsonism Relat Disord. 2017;45:50–6.PubMed
4.
Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain. 2002;125:861–70.PubMed
5.
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, Goetz CG, Golbe LI, Grafman J, Growdon JH, Hallett M, Jankovic J, Quinn NP, Tolosa E, Zee DS. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1–9.PubMed
6.
Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN; NNIPPS Study Group. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain. 2009;132:156–71.PubMed
7.
Davie CA. A review of Parkinson’s disease. Br Med Bull. 2008;86:109–27.PubMed
8.
Marx S, Respondek G, Stamelou M, Dowiasch S, Stoll J, Bremmer F, Oertel WH, Höglinger GU, Einhäuser W. Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson’s disease. Front Behav Neurosci. 2012;6:1–11.
9.
Egerton T, Williams DR, Iansek R. Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults. BMC Neurol. 2012;12:116.PubMedPubMedCentral
10.
Tang CC, Poston KL, Eckert T, Feigin A, Frucht S, Gudesblatt M, Dhawan V, Lesser M, Vonsattel JP, Fahn S, Eidelberg D. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9:149–58.PubMedPubMedCentral
11.
Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, Heinze HJ, Schoenfeld MA. Differentiation of idiopathic Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage. 2004;21:229–35.PubMed
12.
Forkert ND, Schmidt-Richberg A, Treszl A, Hilgetag C, Fiehler J, Münchau A, Handels H, Boelmans K. Automated volumes-of-interest identification for classical and atypical parkinsonian syndrome differentiation using T2’ MR imaging. Methods Inf Med. 2013;52:128–36.PubMed
13.
Duchesne S, Rolland Y, Verin M. Automated computer differential classification in parkinsonian syndromes via pattern analysis on MRI. Acad Radiol. 2009;16:61–70.PubMed
14.
Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, Lanza P, Barone P, Morgante L, Zappia M, Aguglia U, Gallo O. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology. 2008;246:214–21.PubMed
15.
Messina D, Cerasa A, Condino F, Arabia G, Novellino F, Nicoletti G, Salsone M, Morelli M, Lanza PL, Quattrone A. Patterns of brain atrophy in Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy. Parkinsonism Relat Disord. 2011;17:172–6.PubMed
16.
Focke NK, Helms G, Scheewe S, Pantel PM, Bachmann CG, Dechent P, Ebentheuer J, Mohr A, Paulus W, Trenkwalder C. Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls. Hum Brain Mapp. 2011;32:1905–15.PubMed
17.
Gama RL, Távora DF, Bomfim RC, Silva CE, Bruin VM, Bruin PF. Morphometry MRI in the differential diagnosis of parkinsonian syndromes. Arq Neuropsiquiatr. 2010;68:333–8.PubMed
18.
Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, Fox N. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson’s disease. Neuroimage. 2004;23:663–9.PubMed
19.
Scherfler C, Göbel G, Müller C, Nocker M, Wenning GK, Schocke M, Poewe W, Seppi K. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism. Neurology. 2016;86:1242–9.PubMed
20.
Sarica A, Critelli C, Guzzi PH, Cerasa A, Quattrone A, Cannataro M. Application of different classification techniques on brain morphological data. Comput Med Syst (CBMS), 2013 IEEE 26th Int Symp on IEEE. 2013. pp. 425–8.
21.
Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. J Neurol. 2013;260:2094–101.PubMed
22.
Sakurai K, Tokumaru AM, Shimoji K, Murayama S, Kanemaru K, Morimoto S, Aiba I, Nakagawa M, Ozawa Y, Shimohira M, Matsukawa N, Hashizume Y, Shibamoto Y. Beyond the midbrain atrophy: wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology. 2017;59:431–43.PubMed
23.
Dotson VM, Szymkowicz SM, Sozda CN, Kirton JW, Green ML, O’Shea A, McLaren ME, Anton SD, Manini TM, Woods AJ. Age differences in prefrontal surface area and thickness in middle aged to older adults. Front Aging Neurosci. 2016;7:1–9.
24.
Jubault T, Gagnon JF, Karama S, Ptito A, Lafontaine AL, Evans AC, Monchi O. Patterns of cortical thickness and surface area in early Parkinson’s disease. Neuroimage. 2011;55:462–7.PubMed
25.
Gerrits NJ, van Loenhoud AC, van den Berg SF, Berendse HW, Foncke EM, Klein M, Stoffers D, van der Werf YD, van den Heuvel OA. Cortical thickness, surface area and subcortical volume differentially contribute to cognitive heterogeneity in Parkinson’s disease. PLoS ONE. 2016;11:1–14.
26.
Dickerson BC, Feczko E, Augustinack JC, Pacheco J, Morris JC, Fischl B, Buckner RL. Differential effects of aging and Alzheimer’s disease on medial temporal lobe cortical thickness and surface area. Neurobiol Aging. 2009;30:432–40.PubMed
27.
Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown R, Leigh PN, Simmons A. Cortical thickness, surface area and volume measures in Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. PLoS ONE. 2014;9:1–15.
28.
Planetta PJ, Ofori E, Pasternak O, Burciu RG, Shukla P, DeSimone JC, Okun MS, McFarland NR, Vaillancourt DE. Free-water imaging in Parkinson’s disease and atypical parkinsonism. Brain. 2016;139:495–508.PubMed
29.
Hirschauer TJ, Adeli H, Buford JA. Computer-aided diagnosis of Parkinson’s disease using enhanced probabilistic neural network. J Med Syst. 2015;39:179.PubMed
30.
Long D, Wang J, Xuan M, Gu Q, Xu X, Kong D, Zhang M. Automatic classification of early Parkinson’s disease with multi-modal MR imaging. PLoS ONE. 2012;7:1–9.
31.
Péran P, Cherubini A, Assogna F, Piras F, Quattrocchi C, Peppe A, Celsis P, Rascol O, Démonet JF, Stefani A, Pierantozzi M, Pontieri FE, Caltagirone C, Spalletta G, Sabatini U. Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature. Brain. 2010;133:3423–33.PubMed
32.
Morisi R, Cha M, Arafa M, Zagrouba E. Binary and multi-class parkinsonian disorders classification using support vector machines. In: Lecture notes in computer science. 2015. pp. 379–86.
33.
Ota M, Nakata Y, Ito K, Kamiya K, Ogawa M, Murata M, Obu S, Kunugi H, Sato N. Differential diagnosis tool for parkinsonian syndrome using multiple structural brain measures. Comput Math Methods Med. 2013;2013:571289.PubMedPubMedCentral
34.
Segovia F, Illán IA, Górriz JM, Ramírez J, Rominger A, Levin J. Distinguishing Parkinson’s disease from atypical parkinsonian syndromes using PET data and a computer system based on support vector machines and Bayesian networks. Front Comput Neurosci. 2015;9:1–8.
35.
Prashanth R, Dutta Roy S, Mandal PK, Ghosh S. High-accuracy detection of early Parkinson’s disease through multimodal features and machine learning. Int J Med Inform. 2016;90:13–21.PubMed
36.
Boelmans K, Holst B, Hackius M, Finsterbusch J, Gerloff C, Fiehler J, Münchau A. Brain iron deposition fingerprints in Parkinson’s disease and progressive supranuclear palsy. Mov Disord. 2012;27:421–7.PubMed
37.
Fellner F, Holl K, Held P, Fellner C, Schmitt R, Böhm-Jurkovic H. A T1-weighted rapid three-dimensional gradient-echo technique (MP-RAGE) in preoperative MRI of intracranial tumours. Neuroradiology. 1996;38:199–206.PubMed
38.
Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond, B, Biol Sci. 2001;356:1293–322.PubMedPubMedCentral
39.
Ourselin S, Roche A, Subsol G, Pennec X, Ayache N. Reconstructing a 3D structure from serial histological sections. Image Vis Comput. 2001;19:25–31.
40.
Modat M, Ridgway GR, Taylor ZA, Lehmann M, Barnes J, Hawkes DJ, Fox NC, Ourselin S. Fast free-form deformation using graphics processing units. Comput Methods Programs Biomed. 2010;98:278–84.PubMed
41.
Kononenko I, Šimec E, Robnik-Šikonja M. Overcoming the myopia of inductive learning algorithms with RELIEFF. Appl Intell. 1997;7:39–55.
42.
Chang C, Lin C. LIBSVM: A Library for Support Vector Machines. ACM Trans Intell Syst Technol. 2011;2:27:1-27.
43.
Du G, Lewis MM, Kanekar S, Sterling NW, He L, Kong L, Li R, Huang X. Combined diffusion tensor imaging and apparent transverse relaxation rate differentiate Parkinson disease and atypical parkinsonism. AJNR Am J Neuroradiol. 2017;38:966–72.PubMedPubMedCentral
44.
Dubois B, Pillon B. Cognitive deficits in Parkinson’s disease. J Neurol. 1996;244:2–8.
45.
Salvatore C, Cerasa A, Castiglioni I, Gallivanone F, Augimeri A, Lopez M, Arabia G, Morelli M, Gilardi MC, Quattrone A. Machine learning on brain MRI data for differential diagnosis of Parkinson’s disease and progressive supranuclear palsy. J Neurosci Methods. 2014;222:230–7.PubMed
46.
Cherubini A, Morelli M, Nisticó R, Salsone M, Arabia G, Vasta R, Augimeri A, Caligiuri ME, Quattrone A. Magnetic resonance support vector machine discriminates between Parkinson disease and progressive supranuclear palsy. Mov Disord. 2014;29:266–9.PubMed
47.
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.PubMed
48.
Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Höglinger GU. Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol. 2017;16:552–63.PubMedPubMedCentral
Metadata
Title
Improved Automatic Morphology-Based Classification of Parkinson’s Disease and Progressive Supranuclear Palsy
Authors
Aron S. Talai
Zahinoor Ismail
Jan Sedlacik
Kai Boelmans
Nils D. Forkert
Publication date
01-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Neuroradiology / Issue 4/2019
Print ISSN: 1869-1439
Electronic ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-018-0727-8

Other articles of this Issue 4/2019

Clinical Neuroradiology 4/2019 Go to the issue

Original Article

Growth of Asymptomatic Intracranial Fusiform Aneurysms

Original Article

Importance of the First Coil in the Embolization of Intracranial Aneurysms

Clinical Case

Freiburg Neuropathology Case Conference

Correction

Correction to: The unexplained success of stentplasty vasospasm treatment

OriginalPaper

MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma

Original Article

Stent-Retriever Angioplasty for Recurrent Post-Subarachnoid Hemorrhagic Vasospasm – A Single Center Experience with Long-Term Follow-Up